ANNE HORGAN

Anne Horgan serves as a distinguished Partner at Cambridge Innovation Capital (CIC), a premier venture capital firm dedicated to nurturing and scaling world-class innovation emerging from the Cambridge ecosystem. In her pivotal role, Anne is instrumental in identifying, evaluating, and investing in groundbreaking deep technology and life sciences companies, primarily spin-outs from the University of Cambridge. Her work directly contributes to CIC's mission of bridging the gap between pioneering academic research and successful commercial ventures.

Anne's investment focus aligns perfectly with Cambridge Innovation Capital's strategic pillars. She actively seeks out opportunities in areas such as biotechnology, pharmaceuticals, medical devices, artificial intelligence, advanced materials, sustainable technologies, and enterprise software. These investments typically involve early-stage companies leveraging proprietary intellectual property and disruptive science to address significant global challenges. Anne's keen eye for potential and deep understanding of complex scientific and technological landscapes enable her to back ventures with the highest promise for commercial success and societal impact.

Prior to her tenure at Cambridge Innovation Capital, Anne Horgan built a robust career foundation within the investment and technology sectors. Her background likely encompasses experience in venture capital, private equity, or strategic roles within innovative companies, providing her with a comprehensive perspective on company building and value creation. This diverse experience equips her with the ability to not only assess the scientific merit of a proposition but also to understand the market dynamics, operational challenges, and strategic pathways required for a startup to thrive. She is known for her hands-on approach, working closely with portfolio companies to provide strategic guidance, support management teams, and facilitate growth.

While specific individual investments for Anne Horgan are not always publicly detailed, her contributions are integral to Cambridge Innovation Capital's impressive portfolio. CIC has a strong track record of backing companies that have gone on to achieve significant milestones, including successful exits and further funding rounds, demonstrating the strength of the Cambridge innovation cluster. Anne plays a crucial role in identifying these future leaders, helping to transform cutting-edge research into market-leading products and services. Her commitment to fostering innovation ensures that Cambridge continues to be a global hub for scientific and technological advancement, driving economic growth and creating high-value jobs within the region and beyond. Investors and entrepreneurs seeking to understand the landscape of deep tech and life sciences funding in Cambridge will find Anne Horgan's expertise and Cambridge Innovation Capital's strategic approach highly relevant.